Komuta K,Osaki T,Mori M,etc.A phase II study directed by a clinical pathway for carboplatin and weekly paclitaxel in previously untreated patients with unresectable non-small cell lung cancer.[J].2010,1(1).Komuta K, Osaki T, Mori M, Yokota S, Tanio Y, Matsui K, et al. A phase ...
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non–small cell lung cancer. JAMA. 2012;307(15):1593-1601. eTable 1. P Values for the Chi-Square Test Comparing Characteristics Between BCP and CP 2006-7 and Between BCP and CP 2002-5 Elderly Advanced ...
Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapsed Germ Cell Tumor: Clinical Outcome and Quality of Life in Long-Term Su... High-dose chemotherapy (HDCT) is a viable and potentially curative approach for patients with relapsed or refractory germ cell tumors (GC...
PACLITAXELPHYSIOLOGIC salinesQUALITY of lifeNon-small cell lung cancer is a fatal disease associated with high morbidity. It is important to evaluate the effects of treatment on patient's quality of life. Quality of life can be assessed by using EORTC QLQ - C30 and EORTC QLQ ...
Genetic and epigenetic changes contribute to intratumor heterogeneity and chemotherapy resistance in several tumor types. LncRNAs have been implicated, directly or indirectly, in the epigenetic regulation of gene expression. We investigated lncRNAs that